Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-RYVK vs ADENOSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADALIMUMAB-RYVK vs ADENOSINE: Safety Overview

Metric ADALIMUMAB-RYVK ADENOSINE
Total FAERS Reports 463 706
Deaths Reported 48 30
Death Rate 10.4% 4.2%
Hospitalizations 112 309
Average Patient Age 50.0 yrs 46.0 yrs
% Female Patients 63.0% 48.2%
FDA Approval Date N/A Apr 16, 2018
Manufacturer A-S Medication Solutions NOKSIBCHO cosmetic Co., Ltd.
Route SUBCUTANEOUS TOPICAL
Marketing Status Prescription Discontinued